May 22nd, 2020
•The electrochemiluminescence immunoassay (ECLIA) is a novel approach for quantitative detection of endogenous and exogenously applied MeCP2 protein variants, which produces highly quantitative, accurate and reproducible measurements with low intra- and inter-assay error over a wide working range. Here, the protocol for the MeCP2-ECLIA in a 96-well format is described.
Related Videos
Brain Membrane Fractionation: An Ex Vivo Approach to Assess Subsynaptic Protein Localization
Capturing the Interaction Kinetics of an Ion Channel Protein with Small Molecules by the Bio-layer Interferometry Assay
Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay
A Fluorescence Fluctuation Spectroscopy Assay of Protein-Protein Interactions at Cell-Cell Contacts
High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Deciphering Molecular Mechanism of Histone Assembly by DNA Curtain Technique
An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved